CAMBRIDGE, Mass., May 24, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and development company, today announced that Winselow S. Tucker, Jr. has joined Infinity as vice president, marketing, with responsibility for bringing commercial insights to the company’s product development decisions and business development initiatives, as well as leading Infinity’s new product marketing activities. Mr. Tucker has 15 years of commercial pharmaceutical experience in brand leadership and new product marketing, most recently at Novartis Pharmaceuticals where he was the global brand leader for the company’s $4 billion Gleevec® (imatinib) and Tasigna® (nilotinib) franchise in oncology.
